Cryptogenic Stroke, Patent Foramen Ovale Closure, and Mid to Long-term Outcomes: Rising Shadows of Doubt.
作者信息
Dell'Angela Luca, Nicolosi Gian Luigi
机构信息
Division of Cardiology, Cardio-Thoracic and Vascular Department, Gorizia & Monfalcone Hospital, Azienda Sanitaria Universitaria Giuliano Isontina (ASUGI), Gorizia, Italy.
Department of Cardiology, Policlinico San Giorgio, Pordenone, Italy.
出版信息
Korean Circ J. 2023 Sep;53(9):648-649. doi: 10.4070/kcj.2023.0199.
Abstract
摘要
相似文献
1
Cryptogenic Stroke, Patent Foramen Ovale Closure, and Mid to Long-term Outcomes: Rising Shadows of Doubt.
Korean Circ J. 2023 Sep;53(9):648-649. doi: 10.4070/kcj.2023.0199.
2
Author's Reply to Cryptogenic Stroke, Patent Foramen Ovale Closure, and Mid to Long-term Outcomes: Rising Shadows of Doubt.
Korean Circ J. 2023 Sep;53(9):650-651. doi: 10.4070/kcj.2023.1991.
3
Percutaneous closure of a patent foramen ovale after cryptogenic stroke.
Neth Heart J. 2018 Jan;26(1):5-12. doi: 10.1007/s12471-017-1063-3.
4
Cost-effectiveness analysis of patent foramen ovale closure versus medical therapy alone after cryptogenic stroke.
PLoS One. 2022 Jun 3;17(6):e0268690. doi: 10.1371/journal.pone.0268690. eCollection 2022.
5
Patent foramen ovale closure with GORE HELEX or CARDIOFORM Septal Occluder vs. antiplatelet therapy for reduction of recurrent stroke or new brain infarct in patients with prior cryptogenic stroke: Design of the randomized Gore REDUCE Clinical Study.
Int J Stroke. 2017 Dec;12(9):998-1004. doi: 10.1177/1747493017701152. Epub 2017 Mar 24.
6
Patent foramen ovale and cryptogenic stroke: the hole story.
Stroke. 2013 Sep;44(9):2676-8. doi: 10.1161/STROKEAHA.113.001676. Epub 2013 Aug 1.
7
Patent Foramen Ovale Closure for Secondary Prevention of Cryptogenic Stroke: Updated Meta-Analysis of Randomized Clinical Trials.
Am J Med. 2018 May;131(5):575-577. doi: 10.1016/j.amjmed.2017.11.027. Epub 2017 Dec 8.
8
Cryptogenic Strokes and Patent Foramen Ovales: What's the Right Treatment?
Am J Med. 2016 Nov;129(11):1159-1162. doi: 10.1016/j.amjmed.2016.08.006. Epub 2016 Aug 24.
9
Device closure of patent foramen ovale versus medical therapy in cryptogenic stroke: a systematic review and meta-analysis.
JACC Cardiovasc Interv. 2013 Dec;6(12):1316-23. doi: 10.1016/j.jcin.2013.08.001. Epub 2013 Oct 16.
10
Multidisciplinary Assessment in Optimising Results of Percutaneous Patent Foramen Ovale Closure.
Heart Lung Circ. 2017 Mar;26(3):246-250. doi: 10.1016/j.hlc.2016.06.1211. Epub 2016 Aug 5.
引用本文的文献
1
Author's Reply to Cryptogenic Stroke, Patent Foramen Ovale Closure, and Mid to Long-term Outcomes: Rising Shadows of Doubt.
Korean Circ J. 2023 Sep;53(9):650-651. doi: 10.4070/kcj.2023.1991.
本文引用的文献
1
Patent foramen ovale closure after cryptogenic stroke: sometimes uncertain benefit maybe, or even potential harm in the long run?
J Cardiovasc Med (Hagerstown). 2023 Jul 1;24(7):381-391. doi: 10.2459/JCM.0000000000001498. Epub 2023 May 9.
2
Net clinical benefit of PFO closure versus medical treatment in patients with cryptogenic stroke: A systematic review and meta-analysis.
Hellenic J Cardiol. 2023 Mar-Apr;70:46-52. doi: 10.1016/j.hjc.2022.12.010. Epub 2022 Dec 28.
3
Percutaneous Patent Foramen Ovale Closure After Stroke.
Korean Circ J. 2022 Nov;52(11):801-807. doi: 10.4070/kcj.2022.0258.
4
European position paper on the management of patients with patent foramen ovale. General approach and left circulation thromboembolism.
Eur Heart J. 2019 Oct 7;40(38):3182-3195. doi: 10.1093/eurheartj/ehy649.
Zotero 插件